CITIZEN SUIT WATCH: U.S. Supreme Court Agrees to Review Ninth Circuit Decision Requiring Clean Water Act Permits for Forest Roads
Client Alert | 1 min read | 06.25.12
On June 25, 2012, the U.S. Supreme Court granted two petitions for writs of certiorari to review the decision of the U.S. Court of Appeals for the Ninth Circuit in Northwest Environmental Defense Center v. Brown, 640 F.3d 1063 (2011). The Ninth Circuit had ruled that storm water runoff from forest roads is subject to permitting under Clean Water Act section 402, 33 U.S.C. § 1342. The Ninth Circuit rejected the longstanding position of the U.S. Environmental Protection Agency ("EPA") that section 402 permits were not required for such runoff under the Agency's 1976 Silvicultural Rule – a position that EPA reaffirmed in its 1990 stormwater regulations implementing the 1987 amendments to the statute. (For a more detailed discussion of the Ninth Circuit's decision, click here)
Crowell & Moring filed an amicus brief on behalf of the National Alliance of Forest Owners, the American Farm Bureau Federation, and eleven other state and national trade associations all representing forest landowners (together, "Amici";) in support of the two petitions, focusing on the Ninth Circuit’s jurisdictional analysis, in addition to the court’s analysis of the merits under the Clean Water Act. (For a more detailed discussion of the Amici brief, click here.)
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief

